Cargando…

INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression

BACKGROUND: Innate immunity activator (INAVA) has been shown to be elevated in lung adenocarcinoma. However, its expression pattern and function in papillary thyroid cancer (PTC) are unknown. This study aimed to identify the clinical, biological, and mechanistic impacts of INAVA on PTC. METHODS: Usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Hongyu, Guo, Yan, Liu, Liehua, Ye, Runyi, Liang, Weiwei, Li, Hai, Xiao, Haipeng, Li, Yanbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887255/ https://www.ncbi.nlm.nih.gov/pubmed/29632659 http://dx.doi.org/10.1186/s13578-018-0224-4

Ejemplares similares

Long Noncoding RNA LOC100129940-N Is Upregulated in Papillary Thyroid Cancer and Promotes the Invasion and Progression
por: Choy, Manting, et al.
Publicado: (2019)

CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27
por: Li, Hai, et al.
Publicado: (2018)

Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways
por: Guan, Hongyu, et al.
Publicado: (2017)

Single‐cell transcriptomic landscape reveals the differences in cell differentiation and immune microenvironment of papillary thyroid carcinoma between genders
por: Peng, Miaoguan, et al.
Publicado: (2021)

Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2
por: Liang, Weiwei, et al.
Publicado: (2015)

INAVA-ARNO complexes bridge mucosal barrier function with inflammatory signaling
por: Luong, Phi, et al.
Publicado: (2018)

AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9
por: Huang, Lei-Lei, et al.
Publicado: (2017)

Small-molecule modulators of INAVA cytosolic condensate and cell–cell junction assemblies
por: Chang, Denis, et al.
Publicado: (2021)

Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma
por: Xu, Dahai, et al.
Publicado: (2019)

SAT-LB103 Glucose-Dependent Insulinotropic Polypeptide Promotes Proliferation, Inhibits Apoptosis and Modifies Adipogenesis in Human Omental Adipose-Derived Stem Cells
por: Chen, Xueying, et al.
Publicado: (2020)

MON-536 SPOCK1 Promotes the Progression of Papillary Thyroid Cancer ViaPI3K/Akt Signaling Activation
por: Li, Hai, et al.
Publicado: (2020)

TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion
por: Yu, Shuang, et al.
Publicado: (2020)

Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma
por: Fu, Hongliang, et al.
Publicado: (2016)

The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts
por: Guo, Yan, et al.
Publicado: (2023)

Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases
por: Zhang, Yan, et al.
Publicado: (2017)

The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
por: Li, Zhenshengnan, et al.
Publicado: (2023)

Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma
por: Teng, Huajing, et al.
Publicado: (2018)

The indices of body size and aggressiveness of papillary thyroid carcinoma
por: Kim, Ju-Yeon, et al.
Publicado: (2011)

Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
por: Benvenga, Salvatore, et al.
Publicado: (2014)

Management of the Patient with Aggressive and Resistant Papillary Thyroid Carcinoma
por: Miftari, Rame, et al.
Publicado: (2016)

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas
por: Jin, Meihua, et al.
Publicado: (2021)

Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas
por: Warda, Firas, et al.
Publicado: (2022)

Predictive Significance of Two MMP-9 Promoter Polymorphisms and Acetylated c-Jun Transcription Factor for Papillary Thyroid Carcinoma Advancement
por: Rončević, Jelena, et al.
Publicado: (2022)

Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness
por: Zhang, Tao, et al.
Publicado: (2016)

Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma
por: Shi, Yunpeng, et al.
Publicado: (2018)

Multimodality MRI-based radiomics for aggressiveness prediction in papillary thyroid cancer
por: Dai, Zedong, et al.
Publicado: (2022)

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)

LGR5 is associated with tumor aggressiveness in papillary thyroid cancer
por: Michelotti, Gregory, et al.
Publicado: (2015)

Long Noncoding RNA LINC00460 Modulates MMP-9 to Promote Cell Proliferation, Invasion and Apoptosis by Targeting miR-539 in Papillary Thyroid Cancer
por: Zou, Xian, et al.
Publicado: (2020)

Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer
por: Li, Yuanchun, et al.
Publicado: (2020)

Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma
por: Zhou, Yi-Li, et al.
Publicado: (2018)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways
por: Zhang, Jinjun, et al.
Publicado: (2018)

STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
por: He, Weiman, et al.
Publicado: (2023)

SAT-123 Nuclear Receptor 4A1 (NR4A1) Acts as a Tumor Suppressor in Anaplastic Thyroid Cancer
por: Guan, Hongyu, et al.
Publicado: (2020)

The IncRNA SCIRT Promotes the Proliferative, Migratory, and Invasive Properties of Cervical Cancer Cells by Upregulating MMP-2/-9
por: Guan, Chunfeng, et al.
Publicado: (2022)

Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
por: Hong, Shubin, et al.
Publicado: (2023)

Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes
por: Liu, Liehua, et al.
Publicado: (2018)

Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
por: Lee, Cho Rok, et al.
Publicado: (2017)

Recurrent Aggressive Fibromatosis Coexisting With Papillary Carcinoma Thyroid – Case Report
por: BG, Bharath, et al.
Publicado: (2023)

Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm
por: Lee, Jin Seok, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_505hp1hcc25p5a6q31k5r8slb5